A clinical trial to study effect of Dexamethasone on duration of analgesia(pain relief) in brachial plexus block by Bupivacaine(local anaesthetic)

USG guided brachial plexus block: A comparison of analgesia duration using Bupivacaine with and without Dexamethasone as adjuvant.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/023757

Enrollment

Registered

2020-03-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S598- Other specified injuries of elbowand forearm

Interventions

Intervention1: Brachial plexus block: supraclavicular approach Control Intervention1: Brachial plexus block: Dexamethasone 4 mg will be added as adjuvant to the local anaesthetic solution. No repeat d

Eligibility

Inclusion criteria

Inclusion criteria: 1. Posted for Open Reduction Internal Fixation of UpperLimb fractures 2. Upper limb surgery where Supraclavicular brachial plexus block is indicated

Exclusion criteria

Exclusion criteria: 1. Weight less than 40 Kg 2. Pregnancy 3. Poor sensorium (GCS 4. Contraindications to Dexamethasone 5. Diabetes Mellitus 6. Patients on current steroid therapy or within past 6 weeks

Design outcomes

Primary

Measure	Time frame
Compare the duration of Analgesia of brachial plexus block and time to first additional analgesicTimepoint: Measured over 48 hours	—

Secondary

Measure	Time frame
Duration of motor weakness of arm measured every 6 hoursTimepoint: Measured over 48 hours;Postoperative blood sugar every 6 hoursTimepoint: Measured over 48 hours	—

Countries

India

Contacts

Public ContactAditya Sapra

Air Force Hospital

adityasapra@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026